Literature DB >> 28479602

A new vaccination strategy to trigger specific CD4 T-cell response in chronic viral infection.

Allan Randrup Thomsen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28479602      PMCID： PMC6203747          DOI： 10.1038/cmi.2017.19

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN： 1672-7681            Impact factor:   11.530


× No keyword cloud information.
  11 in total

1.  Antigen-specific CD4 T-cell help rescues exhausted CD8 T cells during chronic viral infection.

Authors:  Rachael D Aubert; Alice O Kamphorst; Surojit Sarkar; Vaiva Vezys; Sang-Jun Ha; Daniel L Barber; Lilin Ye; Arlene H Sharpe; Gordon J Freeman; Rafi Ahmed
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-12       Impact factor: 11.205

Review 2.  Immune Memory and Exhaustion: Clinically Relevant Lessons from the LCMV Model.

Authors:  D Zehn; E J Wherry
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

3.  Exhaustion of CTL memory and recrudescence of viremia in lymphocytic choriomeningitis virus-infected MHC class II-deficient mice and B cell-deficient mice.

Authors:  A R Thomsen; J Johansen; O Marker; J P Christensen
Journal:  J Immunol       Date:  1996-10-01       Impact factor: 5.422

4.  Low CD8 T-cell proliferative potential and high viral load limit the effectiveness of therapeutic vaccination.

Authors:  E John Wherry; Joseph N Blattman; Rafi Ahmed
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

Review 5.  T cell exhaustion during persistent viral infections.

Authors:  Shannon M Kahan; E John Wherry; Allan J Zajac
Journal:  Virology       Date:  2015-01-22       Impact factor: 3.616

Review 6.  Innate and Adaptive Immune Regulation During Chronic Viral Infections.

Authors:  Elina I Zuniga; Monica Macal; Gavin M Lewis; James A Harker
Journal:  Annu Rev Virol       Date:  2015-09-02       Impact factor: 10.431

7.  PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells.

Authors:  Erin E West; Hyun-Tak Jin; Ata-Ur Rasheed; Pablo Penaloza-Macmaster; Sang-Jun Ha; Wendy G Tan; Ben Youngblood; Gordon J Freeman; Kendall A Smith; Rafi Ahmed
Journal:  J Clin Invest       Date:  2013-05-15       Impact factor: 14.808

8.  Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy.

Authors:  Se Jin Im; Masao Hashimoto; Michael Y Gerner; Junghwa Lee; Haydn T Kissick; Matheus C Burger; Qiang Shan; J Scott Hale; Judong Lee; Tahseen H Nasti; Arlene H Sharpe; Gordon J Freeman; Ronald N Germain; Helder I Nakaya; Hai-Hui Xue; Rafi Ahmed
Journal:  Nature       Date:  2016-08-02       Impact factor: 49.962

9.  Efficient control of chronic LCMV infection by a CD4 T cell epitope-based heterologous prime-boost vaccination in a murine model.

Authors:  Ran He; Xinxin Yang; Cheng Liu; Xiangyu Chen; Lin Wang; Minglu Xiao; Jianqiang Ye; Yuzhang Wu; Lilin Ye
Journal:  Cell Mol Immunol       Date:  2017-03-13       Impact factor: 11.530

10.  Viral immune evasion due to persistence of activated T cells without effector function.

Authors:  A J Zajac; J N Blattman; K Murali-Krishna; D J Sourdive; M Suresh; J D Altman; R Ahmed
Journal:  J Exp Med       Date:  1998-12-21       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.